CN Stock MarketDetailed Quotes

000403 Pacific Shuanglin Bio-pharmacy

Watchlist
  • 21.39
  • +0.14+0.66%
Market Closed Dec 27 15:00 CST
15.64BMarket Cap18.88P/E (TTM)

Pacific Shuanglin Bio-pharmacy Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
18.75%1.87B
20.82%1.2B
-2.24%532.97M
22.76%2.53B
6.25%1.57B
-0.82%996.15M
17.98%545.2M
18.43%2.06B
21.69%1.48B
40.25%1B
Refunds of taxes and levies
57.41%269.3K
----
----
----
1,120.15%171.08K
-20.84%11.1K
-39.54%154.95K
----
-89.41%14.02K
-84.57%14.02K
Cash received relating to other operating activities
-62.09%30.01M
-34.85%23.31M
79.98%31.5M
62.59%62.46M
11.91%79.16M
-8.53%35.77M
32.95%17.5M
7.45%38.42M
142.61%70.74M
72.88%39.11M
Cash inflows from operating activities
14.88%1.9B
18.89%1.23B
0.29%564.47M
23.49%2.59B
6.51%1.65B
-1.11%1.03B
18.36%562.86M
18.21%2.1B
24.51%1.55B
41.23%1.04B
Goods services cash paid
29.20%991.91M
38.30%629.26M
63.56%352.34M
37.39%1.05B
33.23%767.74M
32.94%455M
28.45%215.42M
4.11%760.88M
4.32%576.25M
4.05%342.26M
Staff behalf paid
11.15%246.46M
16.26%173.61M
16.14%101.95M
4.61%307.68M
3.63%221.73M
-3.23%149.32M
-15.04%87.78M
14.86%294.13M
12.91%213.96M
20.99%154.31M
All taxes paid
15.75%182.53M
8.02%128.23M
-12.29%69.51M
24.34%213.87M
18.10%157.7M
26.85%118.72M
81.33%79.25M
15.50%172M
29.53%133.53M
50.94%93.58M
Cash paid relating to other operating activities
-10.59%250.2M
19.93%182.91M
25.32%92.54M
-0.71%341.6M
-20.30%279.83M
-32.24%152.51M
-10.79%73.84M
50.55%344.03M
82.11%351.11M
94.24%225.08M
Cash outflows from operating activities
17.11%1.67B
27.24%1.11B
35.07%616.34M
21.48%1.91B
11.93%1.43B
7.40%875.55M
14.79%456.29M
15.15%1.57B
22.85%1.27B
28.51%815.23M
Net cash flows from operating activities
0.80%227.53M
-27.83%112.86M
-148.67%-51.86M
29.53%679.01M
-18.45%225.73M
-31.48%156.38M
36.56%106.56M
28.42%524.22M
32.77%276.8M
118.48%228.24M
Investing cash flow
Cash received from disposal of investments
100.00%940M
153.57%710M
23.08%160M
120.90%757.7M
120.66%470M
55.56%280M
--130M
-16.34%343M
-37.39%213M
-25.07%180M
Cash received from returns on investments
891.08%22.69M
1,448.58%21.46M
6,227.89%7.83M
143.66%7.4M
53.10%2.29M
32.34%1.39M
--123.77K
-17.92%3.04M
-24.36%1.5M
6.86%1.05M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
1,364.92%129.57K
6,289.08%63.89K
--10.02K
269.79%1.65M
-98.24%8.84K
-52.17%1K
----
-66.91%445.64K
771.49%501.41K
-95.50%2.09K
Cash received relating to other investing activities
-27.10%41.57M
-27.99%27.96M
--14.05M
-31.06%69.75M
-43.56%57.03M
139.08%38.83M
----
-7.00%101.18M
4.92%101.04M
-80.16%16.24M
Cash inflows from investing activities
89.75%1B
137.18%759.49M
39.79%181.9M
86.86%836.5M
67.49%529.33M
62.31%320.22M
9,994.62%130.12M
-14.54%447.66M
-27.94%316.04M
-38.94%197.29M
Cash paid to acquire fixed assets intangible assets and other long-term assets
-2.57%295.95M
-12.64%190.03M
9.45%111.41M
-0.36%377.27M
22.61%303.75M
40.17%217.53M
45.41%101.79M
16.09%378.64M
-1.66%247.74M
-20.62%155.19M
Cash paid to acquire investments
117.89%1.52B
161.56%1.15B
155.43%510.86M
26.21%748.45M
36.06%698M
6.54%440M
-9.09%200M
4.04%593M
-15.90%513M
-17.40%413M
Cash paid relating to other investing activities
10,106.16%29.13M
----
----
----
-98.73%285.37K
----
----
-89.41%32.4M
-92.68%22.4M
-92.68%22.4M
Cash outflows from investing activities
84.22%1.85B
103.93%1.34B
106.19%622.27M
12.12%1.13B
27.95%1B
11.33%657.53M
-2.65%301.79M
-16.48%1B
-32.94%783.14M
-41.03%590.59M
Net cash flows from investing activities
-78.03%-841.55M
-72.37%-581.4M
-156.52%-440.37M
48.02%-289.21M
-1.20%-472.71M
14.24%-337.31M
44.39%-171.67M
17.97%-556.38M
35.95%-467.1M
42.02%-393.29M
Financing cash flow
Cash received from capital contributions
107.95%14.22M
1,932.13%14.22M
----
230.69%8.3M
1,397.20%6.84M
-72.11%700K
-50.65%700K
-99.84%2.51M
-100.03%-527.34K
-99.84%2.51M
-Including: Cash received from capital contributions by minority shareholders of subsidiaries
----
----
----
----
--700K
--700K
--700K
----
----
----
Cash from borrowing
-7.36%352.08M
-23.91%212.4M
-2.54%117.68M
-9.02%438.32M
0.31%380.05M
15.09%279.13M
7.00%120.74M
58.92%481.79M
-5.20%378.87M
-29.01%242.54M
Cash received relating to other financing activities
486.05%18.22K
----
-99.97%1.94
----
428.31%3.11K
----
3,905.37%6.92K
----
-99.98%588.6
-99.99%316.69
Cash inflows from financing activities
-5.32%366.33M
-19.01%226.63M
-3.11%117.68M
-7.78%446.62M
2.26%386.89M
14.19%279.83M
6.29%121.45M
-74.55%484.3M
-81.05%378.35M
-87.30%245.05M
Borrowing repayment
1.40%265.57M
1.55%180.57M
-21.89%61.4M
20.27%307.08M
38.42%261.91M
255.63%177.81M
686.10%78.61M
-68.93%255.33M
-78.61%189.22M
-93.42%50M
Dividend interest payment
141.50%156.23M
4,247.86%152.48M
28.59%3.02M
32.34%66.79M
29.17%64.69M
-46.67%3.51M
-28.14%2.35M
318.73%50.46M
396.47%50.08M
-31.21%6.58M
-Including:Cash payments for dividends or profit to minority shareholders
----
----
----
----
----
----
----
--800K
--800K
----
Cash payments relating to other financing activities
-83.76%5.17M
-86.65%3.83M
-30.73%1.66M
14.88%34.52M
41.09%31.83M
606.14%28.67M
216.90%2.4M
128.39%30.05M
285.24%22.56M
-11.46%4.06M
Cash outflows from financing activities
19.12%426.98M
60.43%336.88M
-20.73%66.08M
21.60%408.38M
36.88%358.44M
246.31%209.99M
494.51%83.35M
-60.35%335.84M
-70.92%261.87M
-92.17%60.64M
Net cash flows from financing activities
-313.17%-60.65M
-257.86%-110.26M
35.43%51.6M
-74.24%38.24M
-75.57%28.45M
-62.13%69.85M
-61.99%38.1M
-85.94%148.46M
-89.38%116.48M
-84.03%184.42M
Net cash flow
Exchange rate change effecting cash and cash equivalents
-136.09%-23.32K
-82.57%13.67K
113.69%3.82K
98.03%-23.43K
106.13%64.62K
121.63%78.43K
81.10%-27.9K
-420.67%-1.19M
-1,552.54%-1.05M
-1,578.48%-362.64K
Net increase in cash and cash equivalents
-208.84%-674.69M
-421.45%-578.79M
-1,529.97%-440.63M
271.82%428.01M
-191.77%-218.46M
-684.11%-111M
79.30%-27.03M
-85.35%115.11M
-113.00%-74.88M
-96.73%19M
Add:Begin period cash and cash equivalents
42.79%1.43B
42.79%1.43B
42.79%1.43B
13.00%1B
13.00%1B
13.00%1B
13.00%1B
788.38%885.16M
776.64%885.16M
788.38%885.16M
End period cash equivalent
-3.61%753.59M
-4.47%849.49M
1.48%987.65M
42.79%1.43B
-3.51%781.81M
-1.65%889.27M
28.98%973.24M
13.00%1B
19.72%810.28M
32.84%904.16M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash 18.75%1.87B20.82%1.2B-2.24%532.97M22.76%2.53B6.25%1.57B-0.82%996.15M17.98%545.2M18.43%2.06B21.69%1.48B40.25%1B
Refunds of taxes and levies 57.41%269.3K------------1,120.15%171.08K-20.84%11.1K-39.54%154.95K-----89.41%14.02K-84.57%14.02K
Cash received relating to other operating activities -62.09%30.01M-34.85%23.31M79.98%31.5M62.59%62.46M11.91%79.16M-8.53%35.77M32.95%17.5M7.45%38.42M142.61%70.74M72.88%39.11M
Cash inflows from operating activities 14.88%1.9B18.89%1.23B0.29%564.47M23.49%2.59B6.51%1.65B-1.11%1.03B18.36%562.86M18.21%2.1B24.51%1.55B41.23%1.04B
Goods services cash paid 29.20%991.91M38.30%629.26M63.56%352.34M37.39%1.05B33.23%767.74M32.94%455M28.45%215.42M4.11%760.88M4.32%576.25M4.05%342.26M
Staff behalf paid 11.15%246.46M16.26%173.61M16.14%101.95M4.61%307.68M3.63%221.73M-3.23%149.32M-15.04%87.78M14.86%294.13M12.91%213.96M20.99%154.31M
All taxes paid 15.75%182.53M8.02%128.23M-12.29%69.51M24.34%213.87M18.10%157.7M26.85%118.72M81.33%79.25M15.50%172M29.53%133.53M50.94%93.58M
Cash paid relating to other operating activities -10.59%250.2M19.93%182.91M25.32%92.54M-0.71%341.6M-20.30%279.83M-32.24%152.51M-10.79%73.84M50.55%344.03M82.11%351.11M94.24%225.08M
Cash outflows from operating activities 17.11%1.67B27.24%1.11B35.07%616.34M21.48%1.91B11.93%1.43B7.40%875.55M14.79%456.29M15.15%1.57B22.85%1.27B28.51%815.23M
Net cash flows from operating activities 0.80%227.53M-27.83%112.86M-148.67%-51.86M29.53%679.01M-18.45%225.73M-31.48%156.38M36.56%106.56M28.42%524.22M32.77%276.8M118.48%228.24M
Investing cash flow
Cash received from disposal of investments 100.00%940M153.57%710M23.08%160M120.90%757.7M120.66%470M55.56%280M--130M-16.34%343M-37.39%213M-25.07%180M
Cash received from returns on investments 891.08%22.69M1,448.58%21.46M6,227.89%7.83M143.66%7.4M53.10%2.29M32.34%1.39M--123.77K-17.92%3.04M-24.36%1.5M6.86%1.05M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset 1,364.92%129.57K6,289.08%63.89K--10.02K269.79%1.65M-98.24%8.84K-52.17%1K-----66.91%445.64K771.49%501.41K-95.50%2.09K
Cash received relating to other investing activities -27.10%41.57M-27.99%27.96M--14.05M-31.06%69.75M-43.56%57.03M139.08%38.83M-----7.00%101.18M4.92%101.04M-80.16%16.24M
Cash inflows from investing activities 89.75%1B137.18%759.49M39.79%181.9M86.86%836.5M67.49%529.33M62.31%320.22M9,994.62%130.12M-14.54%447.66M-27.94%316.04M-38.94%197.29M
Cash paid to acquire fixed assets intangible assets and other long-term assets -2.57%295.95M-12.64%190.03M9.45%111.41M-0.36%377.27M22.61%303.75M40.17%217.53M45.41%101.79M16.09%378.64M-1.66%247.74M-20.62%155.19M
Cash paid to acquire investments 117.89%1.52B161.56%1.15B155.43%510.86M26.21%748.45M36.06%698M6.54%440M-9.09%200M4.04%593M-15.90%513M-17.40%413M
Cash paid relating to other investing activities 10,106.16%29.13M-------------98.73%285.37K---------89.41%32.4M-92.68%22.4M-92.68%22.4M
Cash outflows from investing activities 84.22%1.85B103.93%1.34B106.19%622.27M12.12%1.13B27.95%1B11.33%657.53M-2.65%301.79M-16.48%1B-32.94%783.14M-41.03%590.59M
Net cash flows from investing activities -78.03%-841.55M-72.37%-581.4M-156.52%-440.37M48.02%-289.21M-1.20%-472.71M14.24%-337.31M44.39%-171.67M17.97%-556.38M35.95%-467.1M42.02%-393.29M
Financing cash flow
Cash received from capital contributions 107.95%14.22M1,932.13%14.22M----230.69%8.3M1,397.20%6.84M-72.11%700K-50.65%700K-99.84%2.51M-100.03%-527.34K-99.84%2.51M
-Including: Cash received from capital contributions by minority shareholders of subsidiaries ------------------700K--700K--700K------------
Cash from borrowing -7.36%352.08M-23.91%212.4M-2.54%117.68M-9.02%438.32M0.31%380.05M15.09%279.13M7.00%120.74M58.92%481.79M-5.20%378.87M-29.01%242.54M
Cash received relating to other financing activities 486.05%18.22K-----99.97%1.94----428.31%3.11K----3,905.37%6.92K-----99.98%588.6-99.99%316.69
Cash inflows from financing activities -5.32%366.33M-19.01%226.63M-3.11%117.68M-7.78%446.62M2.26%386.89M14.19%279.83M6.29%121.45M-74.55%484.3M-81.05%378.35M-87.30%245.05M
Borrowing repayment 1.40%265.57M1.55%180.57M-21.89%61.4M20.27%307.08M38.42%261.91M255.63%177.81M686.10%78.61M-68.93%255.33M-78.61%189.22M-93.42%50M
Dividend interest payment 141.50%156.23M4,247.86%152.48M28.59%3.02M32.34%66.79M29.17%64.69M-46.67%3.51M-28.14%2.35M318.73%50.46M396.47%50.08M-31.21%6.58M
-Including:Cash payments for dividends or profit to minority shareholders ------------------------------800K--800K----
Cash payments relating to other financing activities -83.76%5.17M-86.65%3.83M-30.73%1.66M14.88%34.52M41.09%31.83M606.14%28.67M216.90%2.4M128.39%30.05M285.24%22.56M-11.46%4.06M
Cash outflows from financing activities 19.12%426.98M60.43%336.88M-20.73%66.08M21.60%408.38M36.88%358.44M246.31%209.99M494.51%83.35M-60.35%335.84M-70.92%261.87M-92.17%60.64M
Net cash flows from financing activities -313.17%-60.65M-257.86%-110.26M35.43%51.6M-74.24%38.24M-75.57%28.45M-62.13%69.85M-61.99%38.1M-85.94%148.46M-89.38%116.48M-84.03%184.42M
Net cash flow
Exchange rate change effecting cash and cash equivalents -136.09%-23.32K-82.57%13.67K113.69%3.82K98.03%-23.43K106.13%64.62K121.63%78.43K81.10%-27.9K-420.67%-1.19M-1,552.54%-1.05M-1,578.48%-362.64K
Net increase in cash and cash equivalents -208.84%-674.69M-421.45%-578.79M-1,529.97%-440.63M271.82%428.01M-191.77%-218.46M-684.11%-111M79.30%-27.03M-85.35%115.11M-113.00%-74.88M-96.73%19M
Add:Begin period cash and cash equivalents 42.79%1.43B42.79%1.43B42.79%1.43B13.00%1B13.00%1B13.00%1B13.00%1B788.38%885.16M776.64%885.16M788.38%885.16M
End period cash equivalent -3.61%753.59M-4.47%849.49M1.48%987.65M42.79%1.43B-3.51%781.81M-1.65%889.27M28.98%973.24M13.00%1B19.72%810.28M32.84%904.16M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Blood Products Concept
Blood Products Concept
Intraday+0.72%
Biomedical
Biomedical
Intraday+0.69%
State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday+0.35%